Location History:
- Mountain View, CA (US) (1997 - 1999)
- Palo Alto, CA (US) (2000)
Company Filing History:
Years Active: 1997-2000
Title: Doris L. Slate: Innovator in Chemosensitizing Agents
Introduction
Doris L. Slate is a prominent inventor based in Mountain View, CA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of chemosensitizing agents for cancer treatment. With a total of 5 patents to her name, her work has had a meaningful impact on cancer chemotherapy.
Latest Patents
Among her latest innovations are the 10,11-methanodibenzosuberane derivatives. These compounds are characterized by their unique chemical structure, which includes various substituents that enhance their efficacy as chemosensitizing agents. Specifically, these derivatives are designed to combat multidrug resistance in cancer therapies, making them valuable in the fight against cancer.
Career Highlights
Doris has worked with notable companies, including Syntex (U.S.A.) Inc. Her experience in the pharmaceutical industry has equipped her with the knowledge and skills necessary to innovate in the field of drug development.
Collaborations
Throughout her career, Doris has collaborated with various professionals, including her coworker Jurg R. Pfister. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Doris L. Slate's contributions to the field of pharmaceuticals, particularly in developing chemosensitizing agents, highlight her role as an influential inventor. Her work continues to inspire advancements in cancer treatment and drug development.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.